Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Anal Bioanal Chem ; 414(21): 6285-6294, 2022 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-35129640

RESUMO

Renewable gases, hydrogen and biomethane can be used for the same applications as natural gas: to heat homes, power vehicles and generate electricity. They have the potential to contribute to the decarbonisation of the gas grid. Hydrogen blending with existing natural gas pipelines is also proposed as a means to increase the performance of renewable energy systems. Carbon capture and storage (CCS) and carbon capture and utilisation (CCU) technologies can be an answer to the global challenge of significantly reducing greenhouse gas emissions. Due to production methods, these gases typically contain species in trace amounts that can negatively impact the equipment they come into contact with or pipelines when injected into the gas grid. It is therefore necessary to ensure proper (and stable) gas quality that meets the requirements set out in the relevant standards. The gas quality standards require the collection and transport of a representative gas sample from the point of use to the analytical laboratory; i.e., no compounds may be added to or removed from the gas during sampling and transport. To obtain a representative sample, many challenges must be overcome. The biggest challenge is material compatibility and managing adsorption risks in the sampling systems (sampling line and sampling vessels). However, other challenges arise from the need for flow measurement with non-pure gases or from the nature of the matrix. Currently, there are no conclusive results of short-term stability measurements carried out under gas purity conditions (suitable pressure, matrix, appropriate concentrations, simultaneous presence of several species).


Assuntos
Gases , Gás Natural , Carbono , Dióxido de Carbono/análise , Eletricidade , Hidrogênio
2.
Anal Bioanal Chem ; 398(7-8): 2987-95, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-20890749

RESUMO

Speciation measurements of gadolinium in liposomal MRI contrast agents (CAs) are complicated by the presence of emulsifiers, surfactants, and therapeutic agents in the formulations. The present paper describes two robust, hyphenated chromatography methods for the separation and quantification of gadolinium in nanoemulsion-based CA formulations. Three potential species of gadolinium, free gadolinium ion, gadolinium chelated by diethylenetriamine pentaacetic acid, and gadolinium chelated by 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-diethylenetriaminepentaacetic acid, were present in the CA formulations. The species were separated by reversed-phase chromatography (reversed phase high-performance liquid chromatography, RP-HPLC) or by high-pressure size-exclusion chromatography (HPSEC). For RP-HPLC, fluorescence detection and post-column online isotope dilution inductively coupled plasma mass spectrometry (ID-ICP-MS) were used to measure the amount of gadolinium in each species. Online ID-ICP-MS and species-specific isotope dilution (SID)-ICP-MS were used in combination with the HPSEC column. The results indicated that some inter-species conversions and degradation had occurred within the samples and that SID-ICP-MS should be used to provide the most reliable measurements of total and speciated gadolinium. However, fluorescence and online ID-ICP-MS might usefully be applied as qualitative, rapid screening procedures for the presence of free gadolinium ions.


Assuntos
Quelantes/química , Cromatografia em Gel/métodos , Cromatografia de Fase Reversa/métodos , Meios de Contraste/química , Complexos de Coordenação/química , Gadolínio/química , Imageamento por Ressonância Magnética/métodos , Humanos , Espectrometria de Massas/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA